1-PHENYL-3-[[3-(TRIFLUOROMETHYL)PHENYL]IMINO]-1H-INDOL-2-ONE
生物活性靶点体外研究体内研究 用途与合成方法 MSDS 1-PHENYL-3-[[3-(TRIFLUOROMETHYL)PHENYL]IMINO]-1H-INDOL-2-ONE价格(试剂级) 上下游产品信息
| 中文名称 | 1-PHENYL-3-[[3-(TRIFLUOROMETHYL)PHENYL]IMINO]-1H-INDOL-2-ONE |
|---|---|
| 中文同义词 | 化合物HT-2157 |
| 英文名称 | HT-2157 |
| 英文同义词 | HT-2157;SNAP 37889;1-PHENYL-3-[[3-(TRIFLUOROMETHYL)PHENYL]IMINO]-1H-INDOL-2-ONE;SNAP 37889, CID1471834;HT-2157(SNAP37889);1-phenyl-3-[3-(trifluoromethyl)phenyl]iminoindol-2-one;2H-Indol-2-one, 1,3-dihydro-1-phenyl-3-[[3-(trifluoromethyl)phenyl]imino]-;SNAP-37889 (HT-2157) |
| CAS号 | 303149-14-6 |
| 分子式 | C21H13F3N2O |
| 分子量 | 366.34 |
| EINECS号 | |
| 相关类别 | |
| Mol文件 | 303149-14-6.mol |
| 结构式 | ![]() |
1-PHENYL-3-[[3-(TRIFLUOROMETHYL)PHENYL]IMINO]-1H-INDOL-2-ONE 性质
| 熔点 | 141-144 °C |
|---|---|
| 沸点 | 484.0±55.0 °C(Predicted) |
| 密度 | 1.29±0.1 g/cm3(Predicted) |
| 储存条件 | Store at -20°C |
| 溶解度 | DMF:30.0(最大浓度 mg/mL);81.89(最大浓度 mM) DMSO:44.0(最大浓度 mg/mL);120.11(最大浓度 mM) 乙醇:7.0(最大浓度 mg/mL);19.11(最大浓度 mM) |
| 酸度系数(pKa) | -0.36±0.20(Predicted) |
| 形态 | 固体 |
| 颜色 | 黄至橙色 |
1-PHENYL-3-[[3-(TRIFLUOROMETHYL)PHENYL]IMINO]-1H-INDOL-2-ONE 用途与合成方法
生物活性
HT-2157(SNAP 37889) 是一种选择性的高亲和力甘丙肽-3 受体 (Gal3) 竞争性拮抗剂。
靶点
Galanin-3 receptor
体外研究
HT-2157 (SNAP 37889) binds with high affinity to membranes from transiently transfected LMTK - cells expressing the human Gal 3 receptor (K i =17.44±0.01 nM; n>100) and is highly selective for Gal 3 over the Gal 1 and Gal 2 subtypes (K i >10,000 nM for each subtype; n=46 of each subtype). When tested for the antagonism of galanin-evoked inhibition of adenylyl cyclase, HT-2157 (0.1-10 μM) produces concentration-dependent rightward shifts of the concentration-effect curve to galanin.
体内研究
The galanin-3 receptor antagonist, HT-2157 (SNAP 37889), reduces operant responding for ethanol in alcohol-preferring rats. The novel selective GALR3 antagonist, HT-2157, to reduce anxiety-like behaviour and voluntary ethanol consumption in the iP (alcohol-preferring) rat. Male iP rats treated with HT-2157 at a dose of 30 mg/kg (i.p.) do not show altered locomotor activity or changes in anxiety-like behaviour in the elevated plus maze or light-dark paradigms. Treatment with HT-2157 (30 mg/kg, i.p.) reduces operant responding for solutions containing ethanol, sucrose and saccharin. Collectively, results from the current study shows that HT-2157 (30 mg/kg, i.p.) is effective in reducing operant responding for ethanol, independent of a sedative effect.
安全信息
MSDS信息
1-PHENYL-3-[[3-(TRIFLUOROMETHYL)PHENYL]IMINO]-1H-INDOL-2-ONE 价格(试剂级)
| 更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
|---|---|---|---|---|---|
| 2024/08/19 | HY-100717 | 1-PHENYL-3-[[3-(TRIFLUOROMETHYL)PHENYL]IMINO]-1H-INDOL-2-ONE HT-2157 | 303149-14-6 | 1mg | 900元 |
| 2024/08/19 | HY-100717 | 1-PHENYL-3-[[3-(TRIFLUOROMETHYL)PHENYL]IMINO]-1H-INDOL-2-ONE HT-2157 | 303149-14-6 | 10mM * 1mLin DMSO | 2176元 |
1-PHENYL-3-[[3-(TRIFLUOROMETHYL)PHENYL]IMINO]-1H-INDOL-2-ONE 上下游产品信息
上游原料
1-苯基靛红间氨基三氟甲苯



VIP会员![1-PHENYL-3-[[3-(TRIFLUOROMETHYL)PHENYL]IMINO]-1H-INDOL-2-ONE 结构式](https://yunshiji.oss-cn-shenzhen.aliyuncs.com/202410/29/2052312118800000199.gif)
粤公网安备44196802000105号